scispace - formally typeset
H

Hélène Blanché

Researcher at Fondation Jean Dausset Centre d'Etude du Polymorphisme Humain

Publications -  18
Citations -  2537

Hélène Blanché is an academic researcher from Fondation Jean Dausset Centre d'Etude du Polymorphisme Humain. The author has contributed to research in topics: Longevity & Gene. The author has an hindex of 13, co-authored 18 publications receiving 2111 citations.

Papers
More filters
Journal ArticleDOI

The complete genome sequence of a Neanderthal from the Altai Mountains

TL;DR: It is shown that interbreeding, albeit of low magnitude, occurred among many hominin groups in the Late Pleistocene and a definitive list of substitutions that became fixed in modern humans after their separation from the ancestors of Neanderthals and Denisovans is established.
Journal ArticleDOI

Variation in genomic landscape of clear cell renal cell carcinoma across Europe

TL;DR: The results show that the processes underlyingccRCC tumorigenesis may vary in different populations and suggest that AA may be an important ccRCC carcinogen in Romania, a finding with major public health implications.
Journal ArticleDOI

NF1 Molecular Characterization and Neurofibromatosis Type I Genotype–Phenotype Correlation: The French Experience

TL;DR: An original NF1 investigation strategy is presented and a comprehensive mutation analysis of 565 unrelated patients from the NF‐France Network is reported, pointing out the need to perform an exhaustive NF1 screening in the case of molecular discordant‐related patients.
Journal ArticleDOI

Genome-wide association study identifies multiple risk loci for renal cell carcinoma.

Ghislaine Scelo, +129 more
TL;DR: This paper conducted a meta-analysis of two new scans of 5,198 cases and 7,331 controls together with four existing scans, totalling 10,784 cases and 20,406 controls of European ancestry.
Journal ArticleDOI

New polymorphisms in the human poly(ADP-ribose) polymerase-1 coding sequence: lack of association with longevity or with increased cellular poly(ADP-ribosyl)ation capacity.

TL;DR: The results strongly suggest that the longevity-related differences in the poly(ADP-ribosyl)ation capacity of human lymphoblastoid cell lines cannot be explained by genetic polymorphisms in the PARP-1 coding sequence and that other mechanisms have to be considered as potential regulators of specific poly( ADP- ribosyl]ation capacity.